Zusammenfassung
Die Definition valider Qualitätsindikatoren (QI) ist eine essenzielle Aufgabe der ärztlichen Selbstverwaltung und Qualitätssicherung. Anhand der Literatur und der Ergebnisse des StuDoQ(Studien‑, Dokumentations- und Qualitätszentrum)|Rektumkarzinom-Registers schlagen wir hier folgende QI vor. Rate an CRM(„circumferential resection margin“)-positiven Resektaten, Rate an Anastomoseninsuffizienzen bei Patienten mit angelegter Anastomose, Rate an abdominellen Wundheilungsstörungen, Rate an Patienten mit neuangelegter dauerhaften Harnableitung sowie als neuen Marker den MTL30, welcher das Versterben des Patienten innerhalb von 30 Tagen nach Indexoperation, dessen Verlegung in ein anderes Akutkrankenhaus innerhalb von 30 Tagen oder einen stationären Aufenthalt von über 30 Tagen subsumiert.
Abstract
The definition of valid quality indicators is an essential task of medical self-administration and quality assurance. Based on the literature and the results of the Study, Documentation, and Quality Center (StuDoQ) Rectal Cancer Registry, we suggest the following QIs: rate of circumferential resection margin (CRM) positive resected material, rate of anastomotic leak in patients with anastomoses, rate of abdominal wound healing disorders and rate of patients with newly established permanent urinary diversion. Additionally, a new marker, the MTL30, which subsumes patient death within 30 days after the index operation, patient transfer to another acute hospital within 30 days after the index operation or a length of inpatient hospital stay of more than 30 days.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Fernandez-Martos C, Guerrero A, Minsky B (2012) Clinically relevant study end points in rectal cancer. Recent Results Cancer Res 196:3–19
Burton S et al (2006) MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 94(3):351–357
Pastor C et al (2010) An increase in compliance with the surgical care improvement project measures does not prevent surgical site infection in colorectal surgery. Dis Colon Rectum 53(1):24–30
Pastor C et al (2010) Validation of the risk index category as a predictor of surgical site infection in elective colorectal surgery. Dis Colon Rectum 53(5):721–727
Celentano V et al (2017) Sexual dysfunction following rectal cancer surgery. Int J Colorectal Dis. https://doi.org/10.1007/s00384-017-2826-4
Koushi K et al (2016) Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer. Int J Colorectal Dis 31(12):1845–1852
Andersson J et al (2014) Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II). Br J Surg 101(10):1272–1279
Loos M et al (2013) Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 20(6):1816–1828
Lee SY et al (2015) Risk factors and preventive measures for acute urinary retention after rectal cancer surgery. World J Surg 39(1):275–282
Pollack J et al (2006) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93(12):1519–1525
Wiegering A et al (2017) MTL30 as surrogate parameter for quality of surgically treated diseases: establishment based on the StuDoQ register of the German Society for General and Visceral Surgery. Chirurg. https://doi.org/10.1007/s00104-017-0479-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Wiegering, H.-J. Buhr, C. Klinger, A. Fürst, T. Schiedeck, O. Schwandner, S. Stelzner und C.-T. Germer geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Wiegering, A., Buhr, HJ., Klinger, C. et al. Qualitätsindikatoren für die Chirurgie des Rektumkarzinoms. Chirurg 89, 26–31 (2018). https://doi.org/10.1007/s00104-017-0560-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-017-0560-7